桔梗皂苷D对阿霉素治疗小鼠肺癌的导引机制Guiding mechanism of platycodin D in treatment of mouse lung cancer with doxorubicin
许严伟;耿胜男;王越华;杜钢军;
XU Yan-wei;GENG Sheng-nan;WANG Yue-hua;DU Gang-jun;Zhengzhou University of Industrial Technology;Luoyang Third People's Hospital;Pharmaceutic College of Henan University;
摘要(Abstract):
观察桔梗皂苷D是否对阿霉素治疗小鼠肺癌有导引作用。体外桔梗皂苷D与阿霉素单独或联合加入小鼠Lewis肺癌(LLC)细胞,检测细胞增殖和对阿霉素的摄取;细胞全息分析系统分析细胞形态变化,荧光黄示踪法检测细胞缝隙连接通讯功能,溶酶体示踪红检测细胞溶酶体功能,LC-3B(light chain 3 beta)和P62(heat shock 90-like protein)染色法检测细胞自噬和自噬降解,Western blot法检测细胞P-糖蛋白(P-glycoprotein, P-gp)的表达。体内将小鼠LLC细胞经尾静脉注射接种形成肺实体瘤,桔梗皂苷D与阿霉素单独或联合治疗4周,检测肿瘤大小,记录小鼠存活时间,检测肺组织对阿霉素的摄取,并对肺组织进行HE(hematoxylin-eosin)染色和免疫组化染色。结果显示,桔梗皂苷D在实验浓度不影响LLC细胞增殖,但减少LLC细胞体积,促进细胞摄取阿霉素,增强阿霉素的细胞增殖抑制作用。桔梗皂苷D能促进细胞缝隙连接通讯和细胞溶酶体功能,促进自噬和自噬降解,抑制细胞P-gp表达。桔梗皂苷D在实验剂量对小鼠LLC肺部实体瘤生长无影响,增加肺组织摄取阿霉素和阿霉素对肺实体瘤的治疗效果。桔梗皂苷D改善肺实体瘤细胞外基质沉积,减少肺黏液蛋白5AC(mucin 5AC)分泌和肺血管通透性。总之,桔梗皂苷D对阿霉素治疗小鼠肺癌有导引作用,其机制与促进细胞通讯和溶酶体功能、改善细胞外环境有关。
This study is to observe whether platycodin D has the guiding role in treatment of mouse lung cancer with doxorubicin and explore its guiding mechanism. In vitro, platycodin D and doxorubicin(alone or in combination) were added into Lewis lung cancer(LLC) cells to detect the cell proliferation and doxorubicin uptake. Cell morphological changes were analyzed by cell holographic analysis system; cell gap junctional intercellular communication(GJIC) was tested by fluorescent yellow tracer; lyso-tracker red was used to examine lysosomal function; LC-3 B(Light chain 3 beta)and P62(heat shock 90-like protein)staining were used to test auto-phagy and autophagic degradation respectively; and P-glycoprotein(P-gp) expression was examined by Western blot. In vivo, lung solid tumor was formed in mouse LLC cells via intravenous injection. Platycodin D and doxorubicin(alone or in combination) were used to treat tumor-bearing mice for four weeks, and then the tumor size was examined, mouse survival time was recorded, doxorubicin uptake in lung tissues was tested, and lung tissues were stained for observation by HE(hematoxylin-eosin) and immunohistochemistry. The results showed that platycodin D at the experimental concentration had no effect on LLC cell proliferation but decreased LLC cell volume, promoted the cells to uptake doxorubicin and enhanced the inhibitory action of doxorubicin on cell proliferation. Platycodin D could promote GJIC and lysosomal function, increase autophagy and autophagic degradation and suppress P-gp expression. Platycodin D at the experimental dose in this study had no effect on LLC lung solid tumors in mice, increased doxorubicin uptake in lung tissues and enhanced the therapeutic efficacy of doxorubicin on lung solid tumors. Platycodin D could improve the extracellular matrix deposition in lung solid tumors, decreased the lung mucin 5 AC secretion and pulmonary vessel permeability. In summary, platycodin D had the guiding role in treating mouse lung cancer with doxorubicin, and its guiding mechanism may be associated with the promotion of cell communication, lysosomal function, and improvement of extracellular environment.
关键词(KeyWords):
桔梗皂苷D;阿霉素;肺癌;导引机制
platycodin D;doxorubicin;lung cancer;guiding mechanism
基金项目(Foundation): 河南省自然科学基金项目(182300410310);; 郑州工业应用技术学院校级科研项目(2018YB021);; 洛阳市医疗卫生科技计划项目(1980002A)
作者(Author):
许严伟;耿胜男;王越华;杜钢军;
XU Yan-wei;GENG Sheng-nan;WANG Yue-hua;DU Gang-jun;Zhengzhou University of Industrial Technology;Luoyang Third People's Hospital;Pharmaceutic College of Henan University;
Email:
DOI: 10.19540/j.cnki.cjcmm.20201027.402
参考文献(References):
- [1] 唐镔镔,张喜平.西黄丸对乳腺癌肿瘤微环境调控作用的研究进展[J].中成药,2020,42(5):1276.
- [2] 吴娟,谢晋,张群林,等.中药引经理论的现代研究进展和思路[J].中国中药杂志,2016,41(13):2428.
- [3] 崔泰花,赵熙成,戴雪纯,等.桔梗不同极性溶剂提取物抗氧化活性及成分分析[J].食品科技,2019,44(12):241.
- [4] 韩瑛,张爱青,张俊,等.蟾蜍灵通过调节细胞间隙连接通讯抑制诱导的系膜细胞增殖[J].中国当代儿科杂志,2012,14(12):982.
- [5] 黄修影,卢国栋,廖智红,等.裂果薯皂苷对人肝癌BEL-7402细胞自噬的影响[J].中药材,2019,42(1):178.
- [6] TANG N,DU G J,WANG N,et al.Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin[J].J Natl Cancer Inst,2007,99:1004.
- [7] 左军,尹柏坤,胡晓阳.桔梗化学成分及现代药理研究进展[J].辽宁中医药大学学报,2019,21(1):113.
- [8] 邓亚羚,任洪民,叶先文,等.桔梗的炮制历史沿革、化学成分及药理作用研究进展[J].中国实验方剂学杂志,2020,26(2):190.
- [9] 王琳,王辉.桔梗性能特点及证治机理之新探[J].中医药信息,2019,36(6):52.
- [10] 李杨,夏琦,赵瑞芝,等.引经药桔梗对顺铂在原位肺癌移植瘤裸鼠体内分布的影响[J].中药药理与临床,2018,34(2):71.
- [11] 谢雄雄,张迟,曾金祥,等.中药桔梗的化学成分和药理活性研究进展[J].中医药通报,2018,17(5):66.
- [12] KHAN M,MARYAM A,ZHANG H,et al.Killing cancer with platycodin D through multiple mechanisms[J].Cell Mol Med,2016,20(3):389.
- [13] 王璟,翟鑫,冯正权.冯正权从“虚、痰、毒”论治肺癌经验介绍[J].新中医,2018,50(3):206.
- [14] 赵怡,陈美琪,郝书婷,等.基于网络药理学探讨小柴胡汤抗肺癌作用机制[J].中国实验方剂学杂志,2020,26(9):208.
- [15] 白洁,张光霁.从痰毒互结角度论肺癌与肺痿[J].浙江中医药大学学报,2018,42(4):255.
- [16] 沈政洁,程海波,沈卫星,等.肿瘤炎性微环境与“癌毒”病机相关性探讨[J].北京中医药大学学报,2015,38(1):14.
- [17] 刘瑞,郑红刚,李卫东,等.肺瘤平膏及其联合不同类别药物对肺转移微环境中PI3K/AKT/NF-κB表达的研究[J].中国中药杂志,2018,43(19):3913.
- [18] 罗林明,覃丽,詹济华,等.百合总皂苷对肺癌细胞增殖、凋亡及侵袭转移的作用及其初步机制研究[J].中国中药杂志,2018,43(22):4498.
- [19] XIU L J,SUN D Z,JIAO J P,et al.Anticancer effects of traditional Chinese herbs with phlegm-eliminating properties--an overview[J].J Ethnopharmacol,2015,172:155.
- [20] 徐泳,韩迪,冯凡超,等.华蟾素注射液联合含铂一线化疗方案治疗非小细胞肺癌的Meta分析[J].中国中药杂志,2019,44(21):4728.
- [21] 李智,杨柳.桔梗引经机制及临床配伍应用[J].中国医药导报,2016,13(31):97.
- [22] 柯仲成,侯雪峰,贾晓斌.基于现代中药制剂发展的核心内容探讨引经药的研究思路[J].中草药,2016,47(14):2545.
- [23] 吴丽娜,李杨,李英伦.引经药与药物转运体的研究进展[J].中兽医学杂志,2015(1):67.
- [24] 刘玲琳,徐海滨,胡祖健,等.从CXCL12/CXCR4生物学轴探讨乳移平配伍引经药抗乳腺癌肺转移机理体外研究[J].中华中医药学刊,2015,33(4):924.
- [25] 方雪妮,周天,李泉旺,等.中药对肿瘤微环境各组分的调节作用[J].中华中医药杂志,2018,33(2):631.
- [26] 辛红,徐巍.甘草查尔酮A通过PI3K/Akt/mTOR信号通路诱导肾癌细胞自噬的研究[J].中国中药杂志,2018,43(17):3545.
- [27] CHEN W B,SUN Y Y,GU X P,et al.Conditioned medium of mesenchymal stem cells delays osteoarthritis progression in a rat model by protecting subchondral bone,maintaining matrix homeo-stasis,and enhancing autophagy[J].J Tissue Eng Regen Med,2019,13(9):1618.
- [28] 梁晓强,章学林,马恩伟,等.引经药柴胡对胰腺纤维化大鼠细胞外基质合成调控增效的作用[J].中国中西医结合消化杂志,2012,20(10):433.
- 许严伟
- 耿胜男
- 王越华
- 杜钢军
XU Yan-wei- GENG Sheng-nan
- WANG Yue-hua
- DU Gang-jun
- Zhengzhou University of Industrial Technology
- Luoyang Third People's Hospital
- Pharmaceutic College of Henan University
- 许严伟
- 耿胜男
- 王越华
- 杜钢军
XU Yan-wei- GENG Sheng-nan
- WANG Yue-hua
- DU Gang-jun
- Zhengzhou University of Industrial Technology
- Luoyang Third People's Hospital
- Pharmaceutic College of Henan University